Drug profile · INN
sodium iodide i-131
SODIUM IODIDE I 131
sodium iodide i-131 (SODIUM IODIDE I 131) is an FDA-listed pharmaceutical active ingredient. Associated with Praxis Precision Medicines. Route of administration: oral. Current US regulatory status: approved.
Drug details — sodium iodide i-131
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 20
- Programs
- 2
- Data quality
- 0.89
Quick answer
sodium iodide i-131 (SODIUM IODIDE I 131) is an FDA-listed pharmaceutical active ingredient. Associated with Praxis Precision Medicines. Route of administration: oral. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related patents
-
US 12404297
Salts and crystal forms of GABA-A positive allosteric modulator
granted -
US 12325711
3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-α]pyrazine as an ion channel modulator
granted -
US 12145939
Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators
granted -
WO 2024194388
PREPARATION DE LEVURE SACCHAROMYCES BOULARDII INACTIVEE
granted -
US 11918571
Compounds and their methods of use
granted -
US 11919836
Prodrugs of fencamfamine
granted -
US 11866439
Ion channel modulators
granted -
US 11767325
Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators
granted -
US 11731976
3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator
granted -
US 11731966
Compounds and their methods of use
granted -
US 11731978
3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator
granted -
US 11629146
Substituted [1,2,4]triazolo[4,3-a]pyrazines as modulators of sodium channel activity
granted -
WO 2023046844
COMPOSITIONS PHARMACEUTIQUES UTILES POUR LA PRÉVENTION OU LE TRAITEMENT D'INFECTIONS VIRALES
granted -
US 11492345
Compounds and their methods of use
granted -
FR 3121841
Traitement des hyperammoniémies
granted -
US 11318133
Modulators of integrated stress response pathway
granted -
US 11278535
Compounds and their methods of use
granted -
EP 3964220
PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR BEHANDLUNG VON OSTEOPOROSE
granted -
US 11014931
3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyrazine as an ion channel modulator
granted -
US 10927141
Salts and crystal forms of GABAA positive allosteric modulator
granted
Frequently asked questions
What is sodium iodide i-131?
sodium iodide i-131 (SODIUM IODIDE I 131) is an FDA-listed pharmaceutical active ingredient. Associated with Praxis Precision Medicines. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sodium iodide i-131?
SODIUM IODIDE I 131 is a marketed brand name for sodium iodide i-131. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sodium iodide i-131?
sodium iodide i-131 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.